Chiarella, S. E., Scott Budinger, G. R., & Mutlu, G. M. (2014). β(2)-Agonist therapy may contribute to the air pollution and IL-6–associated risk of developing severe asthma with dual-positive T(H)2/T(H)17 cells. J Allergy Clin Immunol.
Styl ChicagoChiarella, Sergio E., G. R. Scott Budinger, a Gökhan M. Mutlu. "β(2)-Agonist Therapy May Contribute to the Air pollution and IL-6–associated Risk of Developing Severe Asthma With dual-positive T(H)2/T(H)17 Cells." J Allergy Clin Immunol 2014.
Citace podle MLAChiarella, Sergio E., G. R. Scott Budinger, a Gökhan M. Mutlu. "β(2)-Agonist Therapy May Contribute to the Air pollution and IL-6–associated Risk of Developing Severe Asthma With dual-positive T(H)2/T(H)17 Cells." J Allergy Clin Immunol 2014.